To The Moon

  • Home
  • News
  • TigerAI
Log In Sign Up

Hims & Hers Health Stock Surges on Novo Nordisk Partnership for Weight-Loss Drug Sales

Hims & Hers Health Inc. experienced a significant premarket stock price surge of around 38-49% following reports that pharmaceutical giant Novo Nordisk plans to sell its popular weight-loss drugs through Hims & Hers Health's platform. This partnership is seen as a major endorsement of Hims & Hers' business model and is expected to open substantial new revenue streams for the company, driving strong investor enthusiasm and a notable increase in market value.

0 followers
Login to post
  • NewsNews
  • PostsPosts
  • SelectionSelection
    • 据报导,诺和诺德(Novo Nordisk)与Hims公司的合作关系可能会结束法律纠纷,Hims公司股价随之大涨

      03-09
    • Hims & Hers Shares Double on Report of Wegovy Tie-Up

      03-09
    • Hims & Hers Health股价盘前暴涨37.9%,消息称诺和诺德将通过其平台销售减肥药

      03-09
    • Stock Track | Hims & Hers Health Soars 38.56% in Pre-Market on Novo Nordisk Partnership for Weight-Loss Drugs

      03-09
    • 异动解读 | 诺和诺德计划在其平台销售减肥药,Hims & Hers Health盘前暴涨38.56%

      03-09
    • Hims & Hers Health Shares up 37.9% Premarket After Report Novo to Sell Its Weight-Loss Drugs on Co's Platform

      03-09
    • NAI500NAI500
      ·03-11

      From "Bitter Rivals" to "Strong Allies": Hims & Hers Stock Soars 40% Overnight!

      $Novo-Nordisk A/S(NVO)$ $Hims & Hers Health Inc.(HIMS)$ Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims & Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims & Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims & Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims & Hers and Novo Nordisk has be
      看826回复Comment
      点赞Like
      编组 21备份 2Share
      Report
      From "Bitter Rivals" to "Strong Allies": Hims & Hers Stock Soars 40% Overnight!
    • NAI500NAI500
      ·03-11

      From "Bitter Rivals" to "Strong Allies": Hims & Hers Stock Soars 40% Overnight!

      $Novo-Nordisk A/S(NVO)$ $Hims & Hers Health Inc.(HIMS)$ Earlier this year, when Novo Nordisk filed a lawsuit against telehealth platform Hims & Hers (HIMS), the market widely believed the latter’s good days were numbered. However, the plot took a dramatic 180-degree turn shortly after—Novo Nordisk not only dropped the lawsuit but also announced a partnership with Hims & Hers, agreeing to introduce its branded weight-loss drugs to the platform for sale at low prices. Fueled by this news, Hims & Hers’ stock surged 40% on Monday, marking one of its largest single-day gains in history. From Lawsuit to Partnership: A Turbulent Feud The relationship between Hims & Hers and Novo Nordisk has be
      看826回复Comment
      点赞Like
      编组 21备份 2Share
      Report
      From "Bitter Rivals" to "Strong Allies": Hims & Hers Stock Soars 40% Overnight!
Terms and Conditions Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin. Email: uservice@ttm.financial